Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal

Journal of Medical Virology

Volumn 79, Issue 12, 2007, Pages 1889-1897

  Pista, Angela ^a   Oliveira, Ana ^a   Barateiro, Andreia ^a   Costa, Helena ^b   Verdasca, Nuno ^a   Paixão, Maria Teresa ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

Cervical neoplasia; HPV 16; HPV 18; Intratypic variants; Portugal

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN AMERICAN; CANCER INVASION; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; E6 GENE; FEMALE; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PORTUGAL; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM; VIRUS DETECTION; VIRUS GENE; WART VIRUS;

ADULT; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; MUTATION; PHYLOGENY; PORTUGAL; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 35549000463     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21002     Document Type: Article

References (37)

1. Arias-Pulido H, Peyton CL, Torrez-Martínez N, Anderson DN, Wheeler CM. 2005. Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology 338:22-34.
2. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton DL, Bauer HM, Wheeler CM. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment polymorphisms, nucleotide sequence and phylogenetic algorithms. J Infect Dis 170:1077-1085.
3. Berumen J, Ordoñez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, García-Carrancá A, Gonzalez-Lira G, Madrigal-de la Campa A. 2001. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93:1325-1330.
4. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
5. Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A. 2003. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 63:7215-7220.
6. Clifford GM, Smith JS, Plummer M, Munoz N, Fransceschi S. 2003. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88:63-73.
7. de Boer MA, Peters LA, Aziz MF, Sirgar B, Cornain S, Vrede MA, Jordanova ES, Kolkman-Uljee S, Fleuren GJ. 2004. Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 94:488-494.
8. de Boer MA, Peters LA, Aziz MF, Sirgar B, Cornain S, Vrede MA, Jordanova ES, Fleuren GJ. 2005. Human papillomavirus type 18 variants: Histopathology and E6/E7 polymorphisms in three countries. Int J Cancer 114:422-425.
9. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
10. Hildesheim A, Wang SS. 2002. Host and viral genetics and risk of cervical cancer: A review. Virus Res 89:229-240.
11. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apploe RJ, Burk RD. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318.
12. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL, Bernard HU. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 29:1765-1772.
13. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P, Labropoulou V, Mitrani-Rosenbaum S, Norrild M, Pillai MR, Stoerker J, Syrjanen K, Syrjanen S, Tay SK, Villa LL, Wheeler CM, Williamson AL, Bernard HU. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67:6413-6423.
14. Kumar S, Tamura K, Nei M. 2004. MEG A3:Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5:150-163.
15. Lizano M, Berumen J, Guido MC, Casas L, Garcia-Carrancá A. 1997. Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 89:1227-1231.
16. Lizano M, De la Cruz-Hernández E, Carrillo-García A, García-Carrancá A, Ponce de Leon-Rosales S, Dueñas- González A, Hernández-Hernández DM, Mohar A. 2006. Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 102:230-235.
17. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. 1989. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 7:209-214.
18. Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
19. Myers G, Bernard HU, Delius H, Baker C, Icenogle J, Halpern A, Wheeler CM. 1995. A compilation of analysis of nucleic acid and amino acid sequences. Publication LA-UR 95-3675. Los Alamos National Laboratory, Los Alamos, N.M.
20. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M. 1999. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 82:203-207.
21. Ong CK, Chan SY, Campo MS, Fuginaga K, Mavromara-Nazos P, Labropoulou V, Pfister H, Tay SK, Meulen J, Villa LL, Bernard HU. 1993. Evolution of human papillomavirus type 18: An ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67:6424-6431.
22. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
23. Pinheiro PS, Tyczynski JE, Bray F, Amado J, Matos E, Parkin DM. 2003. Cancer incidence and mortality in Portugal. Eur J Cancer 39:2507-2520.
24. st International Papillomavirus Conference (Mexico City, Mexico, 20-26 February, OS 207).
25. Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL. 2003. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 95:1336-1343.
26. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL. 2007. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120:1763-1768.
27. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellate G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Palo G, Franceschi S, Buonaguro FM. 2004. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 74:117-126.
28. Tornesello ML, Duraturo ML, Buonaguro L, Vallefuoco G, Piccoli R, Palmieri S, Buonaguro FM. 2007. Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer 2:1.
29. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959-2968.
30. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
31. Wheeler CM, Yamada T, Hildesheim A, Jenison SA. 1997. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35:11-19.
32. Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK, Galloway DA. 1995. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172:747-755.
33. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802.
34. Xi LF, Carter JJ, Galloway DA, Kuypers J, Hughes JP, Lee SK, Adam DE, Kiviat NB, Koutsky LA. 2002. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11:343-351.
35. Yamada T, Wheeler CM, Halpern AL, Stewart AM, Hildesheim A, Jenison SA. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69:7743-7753.
36. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol 71:2463-2472.
37. Zehbe I, Wilander E, Delius H, Tommasino M. 1998. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833.